Tiziana von Bruchhausen PhD
Boehringer Ingelheim Pharma
Principal Global Pharmacovigilance Writer – Boehringer Ingelheim Pharma
Tiziana has been specialising in pharmacovigilance writing since 2008 and has gained extensive hands-on experience with pharmacovigilance documents and health authorities’ assessments. She has developed broad expertise with the implementation of the GVP guideline related to RMPs and PSURs, and with the evolving concept of safety concerns. In her current position at Boehringer Ingelheim, she is responsible for the coordination and preparation of lifecycle pharmacovigilance documents with a focus on DSURs, RMPs, and PSURs; in addition, she is involved in pre- and post-submission activities related to the global strategic planning and health authorities’ assessment reports.
Tiziana provides trainings on pharmacovigilance writing for professional education institutions Europe-wide, including EMWA. She is an active volunteer for EMWA, where she was Vice President/President in 2017-2019; she has been chairing the Pharmacovigilance Special Interest Group (SIG) since 2017, and since May 2021 she has been on the Committee of the Communicating with the Public SIG.